Stefan K Alig

16PUBLICATIONS
146CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 30, 2026
Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Tomohiro Aoki, Gerben Duns, Shinya Rai

|Nov 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.

Mark P Hamilton, Nick Phillips, Troy Noordenbos

|Sep 26, 2025
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma.

Ajay Subramanian, Shengqin Su, Jamie Flerlage

|Aug 13, 2025
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma.

Mark Roschewski, David M Kurtz, Jason R Westin

|Aug 07, 2025
Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial.

Paolo Strati, Lei Feng, Jason R Westin

|Apr 10, 2025
The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma.

Julia C Kuehn, Nicolas N Neidert, Junyi Zhang

Pageof 3

Frequent Collaborators

12 joint publications

Ash Alizadeh

9 joint publications

David M Kurtz

8 joint publications

Maximilian Diehn

4 joint publications

Jason R Westin